Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9007899 | International Immunopharmacology | 2005 | 14 Pages |
Abstract
These results indicate that the mode of action of PTCF and PCCF on mucosal immune response is different and this is contributed to their metabolites. Taken together, there is a possibility of PTCF and PCCF being therapeutic or preventive agents for immune diseases such as cancer, allergy and parasitic disease through activation of mucosal immune response.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Fumihide Takano, Nobuo Yahagi, Remiko Yahagi, Satoko Takada, Masaya Yamaguchi, Satoko Shoda, Takeshi Murase, Shinji Fushiya, Tomihisa Ohta,